ASCO 2020 - Plenary Session - Pr Thierry AndréLearn more
Genetics and mechanisms involved in resistance to brain tumor treatmentsLearn more
Covid-19. Philosophy and the epidemicLearn more
SiRIC Curamus presentationLearn more
Support the CuramusLearn more
Our ambition is to accelerate research on cancers that are particularly difficult to treat through the development of diagnostic and therapeutic innovations to benefit patients as quickly as possible and thus improve their care and follow-up. We are counting on your support.
Director of Curamus
Cancer United Research Associating Medicine, University & Society
Curamus is one of the eight integrated cancer research sites (SiRIC), certified by the National Cancer Institute (INCa), the Ministry of Solidarity and Health, Inserm and ITMO Cancer AVIESAN (National Alliance for Life Sciences and Health). The SIRIC Curamus aims to bring together and promote the synergy of its multidisciplinary teams around the AP-HP.SORBONNE UNIVERSITY hospital-university group in order to accelerate research and innovation in cancerology to improve care for the benefit of patients.
Curamus is supported by the AP-HP.Sorbonne University Hospital Group and by the 3 faculties of Medicine, Engineering Sciences and Literature of the Sorbonne University under the federation of the University Institute of Cancerology (IUC), in association with their institutional partners, Inserm and CNRS.
Follow the activity of CURAMUS
Stay informed about translational and clinical research in SiRIC CURAMUS
Introduction to AI for predictive oncology and clinical research – virtual lecture
Introduction to AI for predictive oncology and clinical research – virtual lecture June 9 from 10:30 a.m. to 12:00 p.m. […]
Covid-19. Interview with Anne-Geneviève Marcelin, professor of virology
Covid-19. Interview with Anne-Geneviève Marcelin, professor of virology Professor at the Faculty of Medicine and virologist at the Pitié-Salpêtrière Hospital. […]